Literature DB >> 1506920

Protein and energy metabolism in patients with progressive muscular dystrophy.

K Okada1, S Manabe, S Sakamoto, M Ohnaka, Y Niiyama.   

Abstract

Studies were made on whether body weight loss in patients with muscular dystrophy is due to reduced intake and/or abnormal expenditure of energy. For this, food intakes and various physiological variables were surveyed in totals of 310 patients with Duchenne muscular dystrophy (DMD) of 11 to 29 years old and 28 patients with limb-girdle muscular dystrophy (LGMD) of 30 to 47 years old. Energy and protein intakes, expressed on a unit body weight basis, in DMD patients were comparable to, or higher than the allowances for age-matched healthy controls, whereas those in LGMD patients were 92 and 94% respectively of these allowances. The basal metabolic rate (BMR), expressed as kcal/kg/day, of DMD patients of all ages was higher than that of controls, the difference increasing with age, and being about 20 to 30% higher than that of controls in older patients with DMD. The BMR of LGMD patients was nearly normal. The maintenance requirements of conventional dietary protein in DMD and LGMD patients were 1.26 and 0.84 g/kg/day, respectively. These values were about 68 and 12% higher than the normal adult value (0.75 g/kg/day), indicating decreased protein utilization and increased protein catabolism. Daily excretion of urinary 3-methylhistidine (3MH) per unit muscle mass (micrograms/mg creatinine) by MD patients was significantly higher than that by controls, indicating increased degradation of muscle protein. The BMR, maintenance protein requirement and 3MH excretion of DMD patients suggest that DMD is a hypercatabolic disease. Comparison of the energy and protein intakes with the allowances estimated in consideration of increased requirements showed deficiencies of energy and protein in DMD patients. Thus, we conclude that the underweight of the DMD patients resulted from nutrient deficiencies due to hypercatabolism, despite their considerably high intakes of energy and protein, expressed as per kg body weight. These deficiencies were confirmed by demonstrating decreased concentrations of free essential amino acids, particularly branched chain amino acids, in their serum. The values of variables of LGMD patients were intermediate between those of DMD patients and control subjects.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1506920     DOI: 10.3177/jnsv.38.141

Source DB:  PubMed          Journal:  J Nutr Sci Vitaminol (Tokyo)        ISSN: 0301-4800            Impact factor:   2.000


  9 in total

1.  Myocardial atrophy in children with mitochondrial disease and Duchenne muscular dystrophy.

Authors:  Tae Ho Lee; Lucy Youngmin Eun; Jae Young Choi; Hye Eun Kwon; Young-Mock Lee; Heung Dong Kim; Seong-Woong Kang
Journal:  Korean J Pediatr       Date:  2014-05-31

2.  Dysphagia in Duchenne muscular dystrophy: practical recommendations to guide management.

Authors:  Michel Toussaint; Zoe Davidson; Veronique Bouvoie; Nathalie Evenepoel; Jurn Haan; Philippe Soudon
Journal:  Disabil Rehabil       Date:  2016-01-05       Impact factor: 3.033

3.  A modified diet does not ameliorate muscle pathology in a mouse model for Duchenne muscular dystrophy.

Authors:  Ingrid E C Verhaart; Davy van de Vijver; Joke W Boertje-van der Meulen; Kayleigh Putker; Kevin Adamzek; Annemieke Aartsma-Rus; Maaike van Putten
Journal:  PLoS One       Date:  2019-04-24       Impact factor: 3.240

4.  Hypoglycemia in patients with congenital muscle disease.

Authors:  Leslie H Hayes; Pomi Yun; Payam Mohassel; Gina Norato; Sandra Donkervoort; Meganne E Leach; Rachel Alvarez; Anne Rutkowski; Natalie D Shaw; A Reghan Foley; Carsten G Bönnemann
Journal:  BMC Pediatr       Date:  2020-02-06       Impact factor: 2.125

Review 5.  Interactions between gut microbiota and skeletal muscle.

Authors:  Florence Gizard; Anne Fernandez; Filipe De Vadder
Journal:  Nutr Metab Insights       Date:  2020-12-14

6.  The Relationship between Obesity and Clinical Outcomes in Young People with Duchenne Muscular Dystrophy.

Authors:  Natassja Billich; Justine Adams; Kate Carroll; Helen Truby; Maureen Evans; Monique M Ryan; Zoe E Davidson
Journal:  Nutrients       Date:  2022-08-12       Impact factor: 6.706

7.  Dystropathology increases energy expenditure and protein turnover in the mdx mouse model of duchenne muscular dystrophy.

Authors:  Hannah G Radley-Crabb; Juan C Marini; Horacio A Sosa; Liliana I Castillo; Miranda D Grounds; Marta L Fiorotto
Journal:  PLoS One       Date:  2014-02-19       Impact factor: 3.240

Review 8.  Metabogenic and Nutriceutical Approaches to Address Energy Dysregulation and Skeletal Muscle Wasting in Duchenne Muscular Dystrophy.

Authors:  Emma Rybalka; Cara A Timpani; Christos G Stathis; Alan Hayes; Matthew B Cooke
Journal:  Nutrients       Date:  2015-11-26       Impact factor: 5.717

9.  Integrative effects of dystrophin loss on metabolic function of the mdx mouse.

Authors:  Jana Strakova; Forum Kamdar; Debra Kulhanek; Maria Razzoli; Daniel J Garry; James M Ervasti; Alessandro Bartolomucci; DeWayne Townsend
Journal:  Sci Rep       Date:  2018-09-11       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.